SCHEMBL20042853

SCHEMBL20042853

Cc1nc2c(c(N3CCC3)n1)[C@@H](C)N(C(=O)c1cc(Cl)cc(C#N)c1)C2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR6 P46095 2/20 0.34
THRB P10828 2/20 0.33
TP53 P04637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
P2RX7 Q99572 2/20 0.33
LMNA P02545 2/20 0.33
TACR3 P29371 2/20 0.33
KCNH2 Q12809 2/20 0.33
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
HCRTR1 O43613 1/20 0.31
HCRTR2 O43614 1/20 0.31
EGLN2 Q96KS0 1/20 0.31
FASN P49327 3/20 0.31
HPGD P15428 1/20 0.31
TSHR P16473 1/20 0.31
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20043019 0.91 POLB (0.34) TP53TDP1P2RX7TACR3KCNH2
SCHEMBL20042939 0.89 GRM5 (0.40) P2RX7TACR3KCNH2ALDH1A1KDM4E
SCHEMBL20042868 0.88 P2RX7 (0.35) THRBTP53TDP1P2RX7LMNA
SCHEMBL20042843 0.86 GRM5 (0.40) GPR6P2RX7HCRTR1HCRTR2
SCHEMBL20042894 0.86 GRM5 (0.40) GPR6P2RX7HCRTR1HCRTR2
SCHEMBL20042876 0.86 TAS1R3 (0.40) THRBTP53TDP1P2RX7LMNA
SCHEMBL20042986 0.86 TAS1R3 (0.40) THRBTP53TDP1P2RX7LMNA
SCHEMBL20042767 0.85 TACR3 (0.44) P2RX7TACR3KCNH2ALDH1A1FASN
SCHEMBL20042841 0.83 TACR2 (0.45) THRBTP53TDP1LMNATACR3
SCHEMBL20043017 0.83 ALDH1A1 (0.36) THRBP2RX7LMNATACR3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed